Pancreatic Cancer Research

ResearcherNational Cancer Center HospitalActive in the last 2 years

Takanori Kubo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7609-7094; OpenAlex author ID A5000366018. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 3

  1. Antitumor Effect of Oleoyl-siRNA against Pancreatic Cancer Using a Portal Vein Infusion Liver-Metastatic Mouse Model. Co-author DOI 10.1021/acs.molpharmaceut.4c00502↗
  2. A Comparative Study of Patient-Derived Tumor Models of Pancreatic Ductal Adenocarcinoma Involving Orthotopic Implantation. Co-author DOI 10.1159/000521714↗
  3. Development and Biological Analysis of a Novel Orthotopic Peritoneal Dissemination Mouse Model Generated Using a Pancreatic Ductal Adenocarcinoma Cell Line. First author DOI 10.1097/mpa.0000000000001253↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kazuyoshi Yanagihara · 3 shared papers, 2019–2024 · strength 0.48
  2. Toshio Seyama · 3 shared papers, 2019–2024 · strength 0.48
  3. Hiroshi Yokozaki · 2 shared papers, 2019–2022 · strength 0.25
  4. Atsushi Ochiai · 2 shared papers, 2019–2022 · strength 0.25
  5. Tatsuya Oda · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.